Oral Contrast Agent Market, Global Outlook and Forecast 2022-2028

Oral Contrast Agent Market, Global Outlook and Forecast 2022-2028

Report Code: KNJ1281617 | No. of Pages: 78 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Apr-2022
This report contains market size and forecasts of Oral Contrast Agent in global, including the following market information:
Global Oral Contrast Agent Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Oral Contrast Agent Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Oral Contrast Agent companies in 2021 (%)
The global Oral Contrast Agent market was valued at  million in 2021 and is projected to reach US$  million by 2028, at a CAGR of  % during the forecast period.
The U.S. Market is Estimated at $  Million in 2021, While China is Forecast to Reach $  Million by 2028.
Barium-based Contrast Media Segment to Reach $  Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Oral Contrast Agent include GE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany), Guerbet (France), Lantheus (US), Daiichi Sankyo (Japan), Unijules Life Sciences (India), J.B. Chemicals and Pharmaceuticals (India) and Spago Nanomedicine (Sweden), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oral Contrast Agent manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oral Contrast Agent Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Oral Contrast Agent Market Segment Percentages, by Type, 2021 (%)
    Barium-based Contrast Media
    Iodinated Contrast Media
    Gadolinium-based Contrast Media
    Microbubble Contrast Media
Global Oral Contrast Agent Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Oral Contrast Agent Market Segment Percentages, by Application, 2021 (%)
    Cardiovascular Disorders
    Cancer
    Gastrointestinal Disorders
    Musculoskeletal Disorders
    Neurological Disorders
    Nephrological Disorders
Global Oral Contrast Agent Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Oral Contrast Agent Market Segment Percentages, By Region and Country, 2021 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oral Contrast Agent revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Oral Contrast Agent revenues share in global market, 2021 (%)
Key companies Oral Contrast Agent sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Oral Contrast Agent sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
    GE Healthcare (US)
    Bracco Imaging (Italy)
    Bayer HealthCare (Germany)
    Guerbet (France)
    Lantheus (US)
    Daiichi Sankyo (Japan)
    Unijules Life Sciences (India)
    J.B. Chemicals and Pharmaceuticals (India)
    Spago Nanomedicine (Sweden)
    Taejoon Pharm (South Korea)
    Jodas (India)
    Magnus Health (India)
1 Introduction to Research & Analysis Reports
    1.1 Oral Contrast Agent Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Oral Contrast Agent Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Oral Contrast Agent Overall Market Size
    2.1 Global Oral Contrast Agent Market Size: 2021 VS 2028
    2.2 Global Oral Contrast Agent Revenue, Prospects & Forecasts: 2017-2028
    2.3 Global Oral Contrast Agent Sales: 2017-2028
3 Company Landscape
    3.1 Top Oral Contrast Agent Players in Global Market
    3.2 Top Global Oral Contrast Agent Companies Ranked by Revenue
    3.3 Global Oral Contrast Agent Revenue by Companies
    3.4 Global Oral Contrast Agent Sales by Companies
    3.5 Global Oral Contrast Agent Price by Manufacturer (2017-2022)
    3.6 Top 3 and Top 5 Oral Contrast Agent Companies in Global Market, by Revenue in 2021
    3.7 Global Manufacturers Oral Contrast Agent Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Oral Contrast Agent Players in Global Market
        3.8.1 List of Global Tier 1 Oral Contrast Agent Companies
        3.8.2 List of Global Tier 2 and Tier 3 Oral Contrast Agent Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Oral Contrast Agent Market Size Markets, 2021 & 2028
        4.1.2 Barium-based Contrast Media
        4.1.3 Iodinated Contrast Media
        4.1.4 Gadolinium-based Contrast Media
        4.1.5 Microbubble Contrast Media
    4.2 By Type - Global Oral Contrast Agent Revenue & Forecasts
        4.2.1 By Type - Global Oral Contrast Agent Revenue, 2017-2022
        4.2.2 By Type - Global Oral Contrast Agent Revenue, 2023-2028
        4.2.3 By Type - Global Oral Contrast Agent Revenue Market Share, 2017-2028
    4.3 By Type - Global Oral Contrast Agent Sales & Forecasts
        4.3.1 By Type - Global Oral Contrast Agent Sales, 2017-2022
        4.3.2 By Type - Global Oral Contrast Agent Sales, 2023-2028
        4.3.3 By Type - Global Oral Contrast Agent Sales Market Share, 2017-2028
    4.4 By Type - Global Oral Contrast Agent Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
    5.1 Overview
        5.1.1 By Application - Global Oral Contrast Agent Market Size, 2021 & 2028
        5.1.2 Cardiovascular Disorders
        5.1.3 Cancer
        5.1.4 Gastrointestinal Disorders
        5.1.5 Musculoskeletal Disorders
        5.1.6 Neurological Disorders
        5.1.7 Nephrological Disorders
    5.2 By Application - Global Oral Contrast Agent Revenue & Forecasts
        5.2.1 By Application - Global Oral Contrast Agent Revenue, 2017-2022
        5.2.2 By Application - Global Oral Contrast Agent Revenue, 2023-2028
        5.2.3 By Application - Global Oral Contrast Agent Revenue Market Share, 2017-2028
    5.3 By Application - Global Oral Contrast Agent Sales & Forecasts
        5.3.1 By Application - Global Oral Contrast Agent Sales, 2017-2022
        5.3.2 By Application - Global Oral Contrast Agent Sales, 2023-2028
        5.3.3 By Application - Global Oral Contrast Agent Sales Market Share, 2017-2028
    5.4 By Application - Global Oral Contrast Agent Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
    6.1 By Region - Global Oral Contrast Agent Market Size, 2021 & 2028
    6.2 By Region - Global Oral Contrast Agent Revenue & Forecasts
        6.2.1 By Region - Global Oral Contrast Agent Revenue, 2017-2022
        6.2.2 By Region - Global Oral Contrast Agent Revenue, 2023-2028
        6.2.3 By Region - Global Oral Contrast Agent Revenue Market Share, 2017-2028
    6.3 By Region - Global Oral Contrast Agent Sales & Forecasts
        6.3.1 By Region - Global Oral Contrast Agent Sales, 2017-2022
        6.3.2 By Region - Global Oral Contrast Agent Sales, 2023-2028
        6.3.3 By Region - Global Oral Contrast Agent Sales Market Share, 2017-2028
    6.4 North America
        6.4.1 By Country - North America Oral Contrast Agent Revenue, 2017-2028
        6.4.2 By Country - North America Oral Contrast Agent Sales, 2017-2028
        6.4.3 US Oral Contrast Agent Market Size, 2017-2028
        6.4.4 Canada Oral Contrast Agent Market Size, 2017-2028
        6.4.5 Mexico Oral Contrast Agent Market Size, 2017-2028
    6.5 Europe
        6.5.1 By Country - Europe Oral Contrast Agent Revenue, 2017-2028
        6.5.2 By Country - Europe Oral Contrast Agent Sales, 2017-2028
        6.5.3 Germany Oral Contrast Agent Market Size, 2017-2028
        6.5.4 France Oral Contrast Agent Market Size, 2017-2028
        6.5.5 U.K. Oral Contrast Agent Market Size, 2017-2028
        6.5.6 Italy Oral Contrast Agent Market Size, 2017-2028
        6.5.7 Russia Oral Contrast Agent Market Size, 2017-2028
        6.5.8 Nordic Countries Oral Contrast Agent Market Size, 2017-2028
        6.5.9 Benelux Oral Contrast Agent Market Size, 2017-2028
    6.6 Asia
        6.6.1 By Region - Asia Oral Contrast Agent Revenue, 2017-2028
        6.6.2 By Region - Asia Oral Contrast Agent Sales, 2017-2028
        6.6.3 China Oral Contrast Agent Market Size, 2017-2028
        6.6.4 Japan Oral Contrast Agent Market Size, 2017-2028
        6.6.5 South Korea Oral Contrast Agent Market Size, 2017-2028
        6.6.6 Southeast Asia Oral Contrast Agent Market Size, 2017-2028
        6.6.7 India Oral Contrast Agent Market Size, 2017-2028
    6.7 South America
        6.7.1 By Country - South America Oral Contrast Agent Revenue, 2017-2028
        6.7.2 By Country - South America Oral Contrast Agent Sales, 2017-2028
        6.7.3 Brazil Oral Contrast Agent Market Size, 2017-2028
        6.7.4 Argentina Oral Contrast Agent Market Size, 2017-2028
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Oral Contrast Agent Revenue, 2017-2028
        6.8.2 By Country - Middle East & Africa Oral Contrast Agent Sales, 2017-2028
        6.8.3 Turkey Oral Contrast Agent Market Size, 2017-2028
        6.8.4 Israel Oral Contrast Agent Market Size, 2017-2028
        6.8.5 Saudi Arabia Oral Contrast Agent Market Size, 2017-2028
        6.8.6 UAE Oral Contrast Agent Market Size, 2017-2028
7 Manufacturers & Brands Profiles
    7.1 GE Healthcare (US)
        7.1.1 GE Healthcare (US) Corporate Summary
        7.1.2 GE Healthcare (US) Business Overview
        7.1.3 GE Healthcare (US) Oral Contrast Agent Major Product Offerings
        7.1.4 GE Healthcare (US) Oral Contrast Agent Sales and Revenue in Global (2017-2022)
        7.1.5 GE Healthcare (US) Key News
    7.2 Bracco Imaging (Italy)
        7.2.1 Bracco Imaging (Italy) Corporate Summary
        7.2.2 Bracco Imaging (Italy) Business Overview
        7.2.3 Bracco Imaging (Italy) Oral Contrast Agent Major Product Offerings
        7.2.4 Bracco Imaging (Italy) Oral Contrast Agent Sales and Revenue in Global (2017-2022)
        7.2.5 Bracco Imaging (Italy) Key News
    7.3 Bayer HealthCare (Germany)
        7.3.1 Bayer HealthCare (Germany) Corporate Summary
        7.3.2 Bayer HealthCare (Germany) Business Overview
        7.3.3 Bayer HealthCare (Germany) Oral Contrast Agent Major Product Offerings
        7.3.4 Bayer HealthCare (Germany) Oral Contrast Agent Sales and Revenue in Global (2017-2022)
        7.3.5 Bayer HealthCare (Germany) Key News
    7.4 Guerbet (France)
        7.4.1 Guerbet (France) Corporate Summary
        7.4.2 Guerbet (France) Business Overview
        7.4.3 Guerbet (France) Oral Contrast Agent Major Product Offerings
        7.4.4 Guerbet (France) Oral Contrast Agent Sales and Revenue in Global (2017-2022)
        7.4.5 Guerbet (France) Key News
    7.5 Lantheus (US)
        7.5.1 Lantheus (US) Corporate Summary
        7.5.2 Lantheus (US) Business Overview
        7.5.3 Lantheus (US) Oral Contrast Agent Major Product Offerings
        7.5.4 Lantheus (US) Oral Contrast Agent Sales and Revenue in Global (2017-2022)
        7.5.5 Lantheus (US) Key News
    7.6 Daiichi Sankyo (Japan)
        7.6.1 Daiichi Sankyo (Japan) Corporate Summary
        7.6.2 Daiichi Sankyo (Japan) Business Overview
        7.6.3 Daiichi Sankyo (Japan) Oral Contrast Agent Major Product Offerings
        7.6.4 Daiichi Sankyo (Japan) Oral Contrast Agent Sales and Revenue in Global (2017-2022)
        7.6.5 Daiichi Sankyo (Japan) Key News
    7.7 Unijules Life Sciences (India)
        7.7.1 Unijules Life Sciences (India) Corporate Summary
        7.7.2 Unijules Life Sciences (India) Business Overview
        7.7.3 Unijules Life Sciences (India) Oral Contrast Agent Major Product Offerings
        7.7.4 Unijules Life Sciences (India) Oral Contrast Agent Sales and Revenue in Global (2017-2022)
        7.7.5 Unijules Life Sciences (India) Key News
    7.8 J.B. Chemicals and Pharmaceuticals (India)
        7.8.1 J.B. Chemicals and Pharmaceuticals (India) Corporate Summary
        7.8.2 J.B. Chemicals and Pharmaceuticals (India) Business Overview
        7.8.3 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Major Product Offerings
        7.8.4 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Sales and Revenue in Global (2017-2022)
        7.8.5 J.B. Chemicals and Pharmaceuticals (India) Key News
    7.9 Spago Nanomedicine (Sweden)
        7.9.1 Spago Nanomedicine (Sweden) Corporate Summary
        7.9.2 Spago Nanomedicine (Sweden) Business Overview
        7.9.3 Spago Nanomedicine (Sweden) Oral Contrast Agent Major Product Offerings
        7.9.4 Spago Nanomedicine (Sweden) Oral Contrast Agent Sales and Revenue in Global (2017-2022)
        7.9.5 Spago Nanomedicine (Sweden) Key News
    7.10 Taejoon Pharm (South Korea)
        7.10.1 Taejoon Pharm (South Korea) Corporate Summary
        7.10.2 Taejoon Pharm (South Korea) Business Overview
        7.10.3 Taejoon Pharm (South Korea) Oral Contrast Agent Major Product Offerings
        7.10.4 Taejoon Pharm (South Korea) Oral Contrast Agent Sales and Revenue in Global (2017-2022)
        7.10.5 Taejoon Pharm (South Korea) Key News
    7.11 Jodas (India)
        7.11.1 Jodas (India) Corporate Summary
        7.11.2 Jodas (India) Oral Contrast Agent Business Overview
        7.11.3 Jodas (India) Oral Contrast Agent Major Product Offerings
        7.11.4 Jodas (India) Oral Contrast Agent Sales and Revenue in Global (2017-2022)
        7.11.5 Jodas (India) Key News
    7.12 Magnus Health (India)
        7.12.1 Magnus Health (India) Corporate Summary
        7.12.2 Magnus Health (India) Oral Contrast Agent Business Overview
        7.12.3 Magnus Health (India) Oral Contrast Agent Major Product Offerings
        7.12.4 Magnus Health (India) Oral Contrast Agent Sales and Revenue in Global (2017-2022)
        7.12.5 Magnus Health (India) Key News
8 Global Oral Contrast Agent Production Capacity, Analysis
    8.1 Global Oral Contrast Agent Production Capacity, 2017-2028
    8.2 Oral Contrast Agent Production Capacity of Key Manufacturers in Global Market
    8.3 Global Oral Contrast Agent Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Oral Contrast Agent Supply Chain Analysis
    10.1 Oral Contrast Agent Industry Value Chain
    10.2 Oral Contrast Agent Upstream Market
    10.3 Oral Contrast Agent Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Oral Contrast Agent Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com